UK markets close in 5 hours 31 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2800+0.0400 (+3.23%)
At close: 04:00PM EDT
1.2800 0.00 (0.00%)
After hours: 07:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 159.71M
Enterprise value 75.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.86
Enterprise value/revenue N/A
Enterprise value/EBITDA 2.01

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 337.78%
S&P500 52-week change 321.45%
52-week high 32.3100
52-week low 30.6200
50-day moving average 31.5444
200-day moving average 31.0489

Share statistics

Avg vol (3-month) 31.92M
Avg vol (10-day) 3835.06k
Shares outstanding 5125.76M
Implied shares outstanding 6125.76M
Float 8117.92M
% held by insiders 10.06%
% held by institutions 121.76%
Shares short (15 May 2024) 411.48M
Short ratio (15 May 2024) 47.38
Short % of float (15 May 2024) 49.13%
Short % of shares outstanding (15 May 2024) 49.13%
Shares short (prior month 15 Apr 2024) 412.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 320 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-18.85%
Return on equity (ttm)-29.84%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -31.23M
Net income avi to common (ttm)-29.69M
Diluted EPS (ttm)-0.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)83.96M
Total cash per share (mrq)0.67
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)16.34
Book value per share (mrq)0.68

Cash flow statement

Operating cash flow (ttm)-18.62M
Levered free cash flow (ttm)-9.78M